{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:50:54Z","timestamp":1792230654304,"version":"4.4.0"},"reference-count":31,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"unspecified","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","award":["CIGE025ADK01T PROART"],"award-info":[{"award-number":["CIGE025ADK01T PROART"]}],"id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2020,9,22]]},"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Asthma is associated with prolonged time to pregnancy and a higher need for fertility treatment. However, the mechanism underlying this association remains incompletely understood. Previous research points to asthma-driven systemic inflammation also affecting the reproductive organs and thereby fertility. The aim of this study was to determine if treatment with omalizumab prior to fertility treatment will increase pregnancy rate among women with asthma by decreasing the systemic asthma-related inflammation and, by that, to provide insight into the underlying mechanisms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>This is an ongoing prospective multicentre randomised controlled trial planned to enrol 180 women with asthma recruited from fertility clinics in Denmark. The patients are randomised 1:1 to either omalizumab or placebo. The primary endpoint is the difference in pregnancy rate confirmed with ultrasound at gestational week 7 of pregnancy. The secondary endpoints are change in sputum and blood eosinophil cell count, change in biomarkers, change in microbiota, together with rate of pregnancy loss, frequency of malformations, pre-eclampsia, preterm birth, birth weight, small for gestational age and perinatal death between groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>The methods used in this study are of low risk, but if successful, our findings will have a large impact on a large group of patients as infertility and asthma are the most common chronic diseases among the young population. The study has been approved by the Ethics Committee\u2013Danish national research ethics committee (H-18016605) and the Danish Medicines Agency (EudraCT no: 2018-001137-41) and the Danish Data Protection Agency (journal number: VD-2018486 and I-Suite number 6745). The test results will be published regardless of whether they are positive, negative or inconclusive. Publication in international peer-reviewed scientific journals is planned.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>\n                     <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial pre-results\" xlink:href=\"NCT03727971\">NCT03727971<\/jats:ext-link>.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-037041","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T16:11:12Z","timestamp":1605197472000},"page":"e037041","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Treatment with the anti-IgE monoclonal antibody omalizumab in women with asthma undergoing fertility treatment: a proof-of-concept study\u2014The PRO-ART study protocol"],"prefix":"10.1136","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct03727971","registry":"10.18810\/clinical-trials-gov","type":"preResults"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6032-6414","authenticated-orcid":false,"given":"Casper","family":"Tidemandsen","sequence":"first","affiliation":[{"name":"Department of Respiratory Diseases, Hvidovre Hospital, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Juul Gade","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Roskilde Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte Suppli","family":"Ulrik","sequence":"additional","affiliation":[{"name":"Department of Respiratory Diseases, Hvidovre Hospital, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette Svarre","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, The Fertility Clinic, Copenhagen University Hospital, Hvidovre Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte Sophie","family":"Oxlund-Mariegaard","sequence":"additional","affiliation":[{"name":"Fertility Clinic, Copenhagen University Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Kristiansen","sequence":"additional","affiliation":[{"name":"Laboratory of Genomics and Molecular Biomedicine, Department of Biology, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina La Cour","family":"Freiesleben","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, The Fertility Clinic, Copenhagen University Hospital, Hvidovre Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bugge","family":"N\u00f8hr","sequence":"additional","affiliation":[{"name":"Fertility Clinic, Herlev Hospital, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Udengaard","sequence":"additional","affiliation":[{"name":"Fertility Clinic, Herlev Hospital, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke","family":"Backer","sequence":"additional","affiliation":[{"name":"Centre for Physical Activity Research, Rigshospitalet, Kobenhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"key":"2025101812125470000_10.11.e037041.1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/ACI.0000000000000346","article-title":"Asthma guidelines: the global initiative for asthma in relation to national guidelines","volume":"17","author":"Becker","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"2025101812125470000_10.11.e037041.2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01389-2015"},{"key":"2025101812125470000_10.11.e037041.3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00148713"},{"key":"2025101812125470000_10.11.e037041.4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02035-2017"},{"key":"2025101812125470000_10.11.e037041.5","doi-asserted-by":"publisher","DOI":"10.1258\/om.2011.110062"},{"key":"2025101812125470000_10.11.e037041.6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38313.624352.8F"},{"key":"2025101812125470000_10.11.e037041.7","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1080\/14767058.2017.1404982","article-title":"Pregnancy outcomes among women with asthma","volume":"32","author":"Baghlaf","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2025101812125470000_10.11.e037041.8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.rmed.2016.10.004","article-title":"Low risk of adverse obstetrical and perinatal outcome in pregnancies complicated by asthma: a case control study","volume":"120","author":"Ali","year":"2016","journal-title":"Respir Med"},{"key":"2025101812125470000_10.11.e037041.9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.00597-2018","article-title":"Fertility treatment among women with asthma: a case-control study of 3689 women with live births","volume":"53","author":"Vejen Hansen","year":"2019","journal-title":"Eur Respir J"},{"key":"2025101812125470000_10.11.e037041.10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaci.2016.10.046","article-title":"Eosinophilic airway inflammation in asthmatic patients is associated with an altered airway microbiome","volume":"140","author":"Sverrild","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2025101812125470000_10.11.e037041.11","doi-asserted-by":"publisher","DOI":"10.1177\/1753495X18775899"},{"key":"2025101812125470000_10.11.e037041.12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3109\/02770903.2014.966915","article-title":"Lower values of VEGF in endometrial secretion are a possible cause of subfertility in non-atopic asthmatic patients","volume":"52","author":"Gade","year":"2015","journal-title":"J Asthma"},{"key":"2025101812125470000_10.11.e037041.13","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/13.4.1057"},{"key":"2025101812125470000_10.11.e037041.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.01.009"},{"key":"2025101812125470000_10.11.e037041.15","first-page":"4772","article-title":"Vegf-C mediated enhancement of lymphatic drainage reduces intestinal inflammation by regulating IL-9\/IL-17 balance and improving gut microbiota in experimental chronic colitis","volume":"9","author":"Wang","year":"2017","journal-title":"Am J Transl Res"},{"key":"2025101812125470000_10.11.e037041.16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12016-018-8712-1","article-title":"Endotypes, and mechanisms of disease","volume":"56","author":"Kuruvilla","year":"2019","journal-title":"Clinical Reviews in Allergy and Immunology"},{"key":"2025101812125470000_10.11.e037041.17","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1398-9995.2010.02522.x","article-title":"Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma","volume":"66","author":"Bousquet","year":"2011","journal-title":"Allergy"},{"key":"2025101812125470000_10.11.e037041.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.06.032"},{"key":"2025101812125470000_10.11.e037041.19","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.4049\/jimmunol.162.9.5624","article-title":"Down-Regulation of human basophil IgE and Fc epsilon RI alpha surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo","volume":"162","author":"Saini","year":"1999","journal-title":"J Immunol"},{"key":"2025101812125470000_10.11.e037041.20","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jaci.2013.04.056","article-title":"Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation","volume":"132","author":"Macglashan","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"2025101812125470000_10.11.e037041.21","doi-asserted-by":"publisher","DOI":"10.1136\/bjsm.2009.071043"},{"key":"2025101812125470000_10.11.e037041.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2005.02.019"},{"key":"2025101812125470000_10.11.e037041.23","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780010204"},{"key":"2025101812125470000_10.11.e037041.24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2500\/ajra.2012.26.3762","article-title":"The United allergic airway: connections between allergic rhinitis, asthma, and chronic sinusitis","volume":"26","author":"Feng","year":"2012","journal-title":"Am J Rhinol Allergy"},{"key":"2025101812125470000_10.11.e037041.25","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-2397"},{"key":"2025101812125470000_10.11.e037041.26","unstructured":"Andersen A-M , Nielsen HS . Fertilitet og sundhed,\u201d in Fosterlivet: Farefuldt og fantastiske fremtidsudsigter 2012:59\u201382."},{"key":"2025101812125470000_10.11.e037041.27","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jaci.2019.05.019","article-title":"Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort","volume":"145","author":"Namazy","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2025101812125470000_10.11.e037041.28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5114\/pdia.2014.40975","article-title":"Omalizumab in pregnant women treated due to severe asthma: two of good outcomes of pregnancies","volume":"2","author":"Kupry\u015b-Lipi\u0144ska","year":"2014","journal-title":"Pdia"},{"key":"2025101812125470000_10.11.e037041.29","doi-asserted-by":"crossref","first-page":"326","DOI":"10.18176\/jiaci.0179","article-title":"Omalizumab as third-line therapy for urticaria during pregnancy","volume":"27","author":"Ensina","year":"2017","journal-title":"J Investig Allergol Clin Immunol"},{"key":"2025101812125470000_10.11.e037041.30","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2018.1530437"},{"key":"2025101812125470000_10.11.e037041.31","unstructured":"Nielsen HS , Schmidt L , Nyboe Andersen A , et al . Forebyggelse AF nedsat frugtbarhed. K\u00f8benhavn: Vidensr\u00e5d for forebyggelse, 2016: s.23."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-037041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T19:13:04Z","timestamp":1760814784000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-037041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":31,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,12]]},"published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1136\/bmjopen-2020-037041"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-037041","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}